News

BevCanna Announces Product Listings and Purchase Orders from Alberta Gaming and Liquor Commission

August 18, 2021

VANCOUVER, British Columbia–(BUSINESS WIRE)–Emerging leader in innovative health and wellness beverages and products, BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) announces today multiple product listings and purchase orders from Alberta Gaming and Liquor Commission (AGLC). The award-winning and highly anticipated products are expected to be on Alberta shelves by the fall. AGLC…

Details

MedMen Announces Backstopped US$100M Equity Investment Led by Serruya Private Equity to Fund Expansion and Transform Balance Sheet

August 17, 2021

LOS ANGELES–(BUSINESS WIRE)–MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier U.S. cannabis retailer, today announced that investors, led by Serruya Private Equity (“SPE”), are purchasing US$100 million of units (“Units”) of Medmen at a purchase price of US$0.24 (C$0.32) per Unit (the “Private Placement”). Certain investors associated with SPE agreed…

Details

Tilray Acquires Majority Position in Amended MedMen Convertible Notes

August 17, 2021

NEW YORK & LOS ANGELES–(BUSINESS WIRE)–Tilray, Inc. (“Tilray”) (Nasdaq l TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, and MedMen Enterprises Inc. (“MedMen”) (CSE: MMEN) (OTCQX: MMNFF), a premier American cannabis retailer, today announced that Tilray has acquired the majority of the outstanding senior secured convertible notes (the “Notes”) of MedMen that…

Details

Marinus Pharmaceuticals Reports Topline Ganaxolone Phase 2 Open-Label Results in Tuberous Sclerosis Complex and Receives FDA Orphan Drug Designation

August 17, 2021

RADNOR, Pa.–(BUSINESS WIRE)–Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC). The primary endpoint showed…

Details

Veterinarian-Founded CBD Company VETCBD Hemp Announces Scholarship Program for Veterinary Students

August 17, 2021

LOS ANGELES–(BUSINESS WIRE)–Veterinarian-founded cannabis company VETCBD Hemp today announced that applications are open for its inaugural Memorial Scholarship Program for veterinary students, veterinary technicians and veterinary technician students across the nation. With this program, VETCBD gives back to the veterinary community while investing in the future of veterinary medicine and research. Each $1,000 scholarship awarded…

Details

World Respiratory Health Management Technology Market Report 2021 Featuring Clin-e-cal, Cognita Labs, Qure AI, ResApp Health Limited, & Zebra Medical Vision – ResearchAndMarkets.com

August 17, 2021

DUBLIN–(BUSINESS WIRE)–The “Respiratory Health Management Technology Growth Opportunities” report has been added to ResearchAndMarkets.com’s offering. This growth opportunity-technology report explores innovations and patents in this space and provides more details about notable companies that are making strides in research and development. It includes explanations about the drivers and restraints that will shape the market through…

Details

Flora Growth Signs Agreement To Acquire Industry-Leading Vessel Brand, Entering Luxury Cannabis Consumer Technology Segment

August 17, 2021

MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to announce that it has signed a Letter of Intent (the “LOI”) to acquire 100% of Vessel Brand Inc. (“Vessel”). Vessel is designing the cannabis and wellness industries forward…

Details

TILT Holdings Graduates Public Listing to the NEO Exchange

August 17, 2021

TORONTO–(BUSINESS WIRE)–NEO is proud to welcome TILT Holdings Inc. (“TILT”) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, as they upgrade their public listing to the NEO Exchange. Following a voluntary delisting from the Canadian Securities Exchange, TILT is now available for trading…

Details

Receptor Life Sciences Announces Publication of Proof-of-Principle Clinical Pharmacokinetics Study of RLS103 (Inhaled Dry Powder CBD)

August 17, 2021

SEATTLE–(BUSINESS WIRE)–Receptor Life Sciences (RLS), a pharmaceutical company developing innovative therapies to address central nervous system disorders, announced the publication of a manuscript in the Journal of Pharmaceutical Sciences. The paper reports cannabidiol (CBD) pharmacokinetics (PK) in healthy volunteers following inhalation of RLS103, an investigational inhaled dry powder CBD. RLS103 is being developed for the…

Details

CURE Pharmaceutical Reports Second Quarter 2021 Revenue Rose Nearly 700% Driven by Sales from Sera Labs Product Lines

August 17, 2021

OXNARD, Calif.–(BUSINESS WIRE)–CURE Pharmaceutical Holding Corp. (OTC: CURR), today announced results for the quarter ended June 30, 2021, including the following highlights: Revenue of $2.1 million reflected an increase of nearly 700% from a year ago Gross profit rose 676% to $1.31 million compared to 2Q 2020 Net loss from operations of $3.27 million improved…

Details

Cresco Labs to Acquire a Top Performing Maryland Dispensary, Blair Wellness Center

August 17, 2021

CHICAGO–(BUSINESS WIRE)–Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, announced today the execution of a definitive agreement to acquire 100% of the outstanding equity interests in Blair Wellness, LLC (“Blair Wellness”), a Baltimore, Maryland medical cannabis dispensary (the “Transaction”).…

Details

Organigram Launches Edison JOLTS, Reinvents the Ingestible Extract

August 17, 2021

MONCTON, New Brunswick–(BUSINESS WIRE)–Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce the launch of Edison Cannabis Co. (“Edison”) JOLTS, Canada’s first flavoured high potency THC lozenge. Edison JOLTS are available in a package of 10 mint…

Details